|
Volumn 38 Suppl 5, Issue , 2002, Pages
|
Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
STEM CELL FACTOR RECEPTOR;
TUMOR PROTEIN;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
CONNECTIVE TISSUE TUMOR;
DRUG ANTAGONISM;
DRUG RESISTANCE;
GASTROINTESTINAL TUMOR;
HUMAN;
REVIEW;
STROMA CELL;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
ENZYME INHIBITORS;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
NEOPLASM PROTEINS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASMS, CONNECTIVE TISSUE;
PIPERAZINES;
PROTEIN-TYROSINE KINASES;
PROTO-ONCOGENE PROTEINS C-KIT;
PYRIMIDINES;
RECEPTOR PROTEIN-TYROSINE KINASES;
STROMAL CELLS;
TOMOGRAPHY, EMISSION-COMPUTED;
MLCS;
MLOWN;
|
EID: 0036770178
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/s0959-8049(02)80603-7 Document Type: Review |
Times cited : (117)
|
References (28)
|